Remove 2023 Remove Diabetes Remove Hypertension
article thumbnail

Understanding the hidden burden: prevalence and factors linked to left ventricular hypertrophy in hypertensive patients receiving care in Harari region, Ethiopia

Frontiers in Cardiovascular Medicine

BackgroundLeft ventricular hypertrophy (LVH) is often a complication of hypertension and an independent risk factor for cardiovascular events. In Ethiopia, there is a scarcity of data on the prevalence and associated factors of left ventricular hypertrophy among hypertensive adults. p-values of <0.05 in the study population.

article thumbnail

Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study

Cardiovascular Diabetology

We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati.

article thumbnail

Kidney Week 2023: Top Ten Takeaways

Cardiometabolic Health Congress

2-5, 2023, to gain perspective on the latest advances in the management of glomerular disease. Kidney Week 2023 not only served as a platform for the latest news and updates in the field but also marked the final meeting of the year for practitioners in the specialty of nephrology.

article thumbnail

Very high LDL no impact on plaque progression

Dr. Malcolm Kendrick

10th December 2023 A very important study – please watch Very high low density lipoprotein levels with no impact on plaque progression I interrupt my series on what is wrong with the health service to bring you breaking news. They were all healthy with none of them having diabetes, or hypertension, meaning that they were well matched.

Plaque 144
article thumbnail

Risk Assessment Score and Chi-Square Automatic Interaction Detection Algorithm for Hypertension Among Africans: Models From the SIREN Study

Hypertension Journal

Hypertension, Volume 80, Issue 12 , Page 2581-2590, December 1, 2023. BACKGROUND:This study aimed to develop a risk-scoring model for hypertension among Africans.METHODS:In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. for the training set and 64.6% (95% CI, 61.0–68.0)

article thumbnail

Abstract WP137: 10-Year Trends in Last Known Well to Arrival Time in Acute Ischemic Stroke Patients: 2014-2023

Stroke Journal

Our purpose was to evaluate the 10-year trends in the last known well to arrival (LKWA) time in AIS patients and assess disparities.Methods:A retrospective study of consecutive AIS patients admitted to a large integrated healthcare system was performed over a 10-year period from 2014-2023. 1.66]), and comorbidities of diabetes (1.29 [1.18-1.41]),

article thumbnail

Exploring Obesity and the Latest Advances in Weight Loss Drugs during Healthy Weight Week

Cardiometabolic Health Congress

It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high blood pressure. Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension.

Obesity 97